BDBM218313 (r)-6-((1- cyclobutylethyl)amino)- 8-(1-methyl-1h- imidazol-2-yl)-7-(4- (trifluoromethyl) benzyl)-7h-purine-2- carboxylic acid::US9540377, 3.1

SMILES C[C@@H](Nc1nc(nc2nc(-c3nccn3C)n(Cc3ccc(cc3)C(F)(F)F)c12)C(O)=O)C1CCC1

InChI Key InChIKey=YVTNTPOCURPKIU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 218313   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 218313BDBM218313(US9540377, 3.1 | (r)-6-((1- cyclobutylethyl)amino)...)
Affinity DataIC50: 161nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent